Abstract: An apparatus for installing or replacing license software such as in a device or secure digital card of a controller. The apparatus may have a door that is situated in a base of the controller. The door may slide down to provide an opening that permits access to a place, an area or receptacle that holds the card. The door may not necessarily be open-able until the controller is removed from a panel, a din rail, or some other structure, where a removal of power has to occur. The door may be designed so that it blends in with the base in that just qualified installers are aware of how to find the door for access to the card. To close the door, the card needs to be fully installed before the door can be closed. The door may be designed with hook features to prevent its removal from the controller base.

Abstract: Articles of footwear having both interior and exterior midsole components may include: (a) an upper that at least in part defines an interior chamber; (b) an interior midsole component within the interior chamber, wherein, at a forefoot region, the interior midsole component includes a longitudinal flexion line and a plurality of transverse flexion lines; and (c) an exterior sole structure engaged with the upper. This exterior sole structure may include: (a) an exterior midsole component in a heel region of the article of footwear that does not extend under the forefoot region of the article of footwear and (b) an outsole component that extends under the forefoot region. If desired, the outsole component may extend under the exterior midsole component in the rearfoot region. The interior midsole component may include a plurality of pod elements separated from one another by the flexion lines.

Abstract: An article of footwear includes an upper that at least in part defines an interior chamber for receiving a foot; an insertable interior midsole component received within the interior chamber; and an exterior sole structure engaged with the upper, wherein the exterior sole structure includes: (a) an exterior midsole component and (b) optionally an outsole component that extends under the forefoot region, wherein the insertable interior midsole component is formed from a foam material comprising a reaction product of about 10 to about 100 phr hydrogenated or non-hydrogenated acrylonitrile butadiene copolymer, 0 to about 40 phr modified hydrogenated acrylonitrile butadiene copolymer, and 0 to about 90 phr alpha olefin copolymer, and at least one additive in an amount suitable to form the foam material; wherein the density of the foam material is less than 0.25 g/cm3.

Abstract: An apparatus for installing or replacing license software such as in a device or secure digital card of a controller. The apparatus may have a door that is situated in a base of the controller. The door may slide down to provide an opening that permits access to a place, an area or receptacle that holds the card. The door may not necessarily be open-able until the controller is removed from a panel, a din rail, or some other structure, where a removal of power has to occur. The door may be designed so that it blends in with the base in that just qualified installers are aware of how to find the door for access to the card. To close the door, the card needs to be fully installed before the door can be closed. The door may be designed with hook features to prevent its removal from the controller base.

Abstract: An article of footwear includes an upper that at least in part defines an interior chamber for receiving a foot; an insertable interior midsole component received within the interior chamber; and an exterior sole structure engaged with the upper, wherein the exterior sole structure includes: (a) an exterior midsole component and (b) optionally an outsole component that extends under the forefoot region, wherein the insertable interior midsole component is formed from a foam material comprising a reaction product of about 10 to about 100 phr hydrogenated or non-hydrogenated acrylonitrile butadiene copolymer, 0 to about 40 phr modified hydrogenated acrylonitrile butadiene copolymer, and 0 to about 90 phr alpha olefin copolymer, and at least one additive in an amount suitable to form the foam material; wherein the density of the foam material is less than 0.25 g/cm3.

Abstract: An article of footwear includes an upper that at least in part defines an interior chamber for receiving a foot; an insertable interior midsole component received within the interior chamber; and an exterior sole structure engaged with the upper, wherein the exterior sole structure includes: (a) an exterior midsole component and (b) optionally an outsole component that extends under the forefoot region, wherein the insertable interior midsole component is formed from a foam material comprising a reaction product of about 10 to about 100 phr hydrogenated or non-hydrogenated acrylonitrile butadiene copolymer, 0 to about 40 phr modified hydrogenated acrylonitrile butadiene copolymer, and 0 to about 90 phr alpha olefin copolymer, and at least one additive in an amount suitable to form the foam material; wherein the density of the foam material is less than 0.25 g/cm3.

Abstract: Articles of footwear having both interior and exterior midsole components may include: (a) an upper that at least in part defines an interior chamber; (b) an interior midsole component within the interior chamber, wherein, at a forefoot region, the interior midsole component includes a longitudinal flexion line and a plurality of transverse flexion lines; and (c) an exterior sole structure engaged with the upper. This exterior sole structure may include: (a) an exterior midsole component in a heel region of the article of footwear that does not extend under the forefoot region of the article of footwear and (b) an outsole component that extends under the forefoot region. If desired, the outsole component may extend under the exterior midsole component in the rearfoot region. The interior midsole component may include a plurality of pod elements separated from one another by the flexion lines.

Abstract: An article of footwear is provided and includes an upper structure having a heel portion and a forefoot portion and a plate attached to a bottom surface of the upper structure. A sole structure is attached to the plate and includes a first portion associated with the heel portion and a second portion associated with the forefoot portion. The first portion includes a wall formation having a continuous structure with a series of peaks disposed proximate to and in contact with the plate and a series of valleys cooperating with the peaks to define a plurality of pockets formed through the wall formation.

Abstract: Glypican 5 is shown for the first time to have a role in proliferation of cancer cells, including tumours which do not show chromosomal amplification at 13q31. The use of glypican 5 (GPC5) antagonists and binding agents for the treatment of cancer, particularly rhabdomyosarcoma and breast cancer, is disclosed.

Abstract: An article of footwear is provided and includes an upper structure having a heel portion and a forefoot portion and a plate attached to a bottom surface of the upper structure. A sole structure is attached to the plate and includes a first portion associated with the heel portion and a second portion associated with the forefoot portion. The first portion includes a wall formation having a continuous structure with a series of peaks disposed proximate to and in contact with the plate and a series of valleys cooperating with the peaks to define a plurality of pockets formed through the wall formation.

Abstract: Glypican 5 is shown for the first time to have a role in proliferation of cancer cells, including tumors which do not show chromosomal amplification at 13q31. The use of glypican 5 (GPC5) antagonists and binding agents for the treatment of cancer, particularly rhabdomyosarcoma and breast cancer, is disclosed.

Abstract: Glypican 5 is shown for the first time to have a role in proliferation of cancer cells, including tumours which do not show chromosomal amplification at 13q31. The use of glypican 5 (GPC5) antagonists and binding agents for the treatment of cancer, particularly rhabdomyosarcoma and breast cancer, is disclosed.

Abstract: A gas-powered, durable, needle-less hypodermic jet injection device (10, 210) includes a hand-held injector (12, 212) which receives into an injection cylinder a volume of liquid medication to be injected in the form of a high velocity jet capable of penetrating the skin without the use of a hypodermic needle. The injection device provides an injection orifice, and an injection piston. Forceful movement of the injection piston causes a high velocity injection jet of liquid medication to be expelled from the injection cylinder via the injection orifice. The injection device includes features which improve its usability, particularly for users with hands that are possibly weak, feeble, or arthritic, for example; and also includes additional features which improve manufacturability, durability, and cost effectiveness of the device.

Abstract: A gas-powered, durable, needle-less hypodermic jet injection device (10, 210) includes a hand-held injector (12, 212) which receives into an injection cylinder a volume of liquid medication to be injected in the form of a high velocity jet capable of penetrating the skin without the use of a hypodermic needle. The injection device provides an injection orifice, and an injection piston. Forceful movement of the injection piston causes a high velocity injection jet of liquid medication to be expelled from the injection cylinder via the injection orifice. The injection device includes features which improve its usability, particularly for users with hands that are possibly weak, feeble, or arthritic, for example; and also includes additional features which improve manufacturability, durability, and cost effectiveness of the device.

Abstract: A method of making a mold from a model is disclosed. A mold carrier is formed having an aperture therein. The aperture has a configuration generally corresponding to the shape of the model. The model is positioned within the aperture such that a space is created between the outer peripheral surface of the aperture and the outer peripheral surface of the model. A resilient first material in its liquid state is poured into the space such that the first material substantially covers the outer peripheral surface of the model. The resilient first material is allowed to solidify in the space such that a resilient mold insert is formed. The mold insert forms an impression of the outer peripheral surface of the model and is disposed along the inner peripheral surface of the aperture. The model is removed from the resilient mold insert. A second material in its liquid state is poured into the aperture of the mold carrier with the resilient mold insert disposed along the inner peripheral surface of the aperture.

Abstract: A method of making a mold from a model is disclosed. A mold carrier is formed having an aperture therein. The aperture has a configuration generally corresponding to the shape of the model. The model is positioned within the aperture such that a space is created between the outer peripheral surface of the aperture and the outer peripheral surface of the model. A resilient first material in its liquid state is poured into the space such that the first material substantially covers the outer peripheral surface of the model. The resilient first material is allowed to solidify in the space such that a resilient mold insert is formed. The mold insert forms an impression of the outer peripheral surface of the model and is disposed along the inner peripheral surface of the aperture. The model is removed from the resilient mold insert. A second material in its liquid state is poured into the aperture of the mold carrier with the resilient mold insert disposed along the inner peripheral surface of the aperture.

Abstract: A process for preparing an improved urea-formaldehyde concentrate particularly adapted for production of slow-release nitrogenous fertilizers. The improvement is achieved by accurately controlling the buffer strength and the degree of polymerization of the urea-formaldehyde concentrate within specified critical limits. The process can be operated to also produce a different urea-formaldehyde concentrate suitable for use in adhesives.